Prestige Brands (PBH) Tops Q4 EPS by 1c, Revenues Beat; Affirms FY20 EPS Mid-Point Guidance Below Consensus, Provides FY20 Revenue Outlook, Board Approves New $50M Buyback

Go back to Prestige Brands (PBH) Tops Q4 EPS by 1c, Revenues Beat; Affirms FY20 EPS Mid-Point Guidance Below Consensus, Provides FY20 Revenue Outlook, Board Approves New $50M Buyback

Prestige Consumer Healthcare Inc. Reports Fiscal 2019 Fourth Quarter and Full-Year Results

May 9, 2019 6:02 AM EDT

Revenue was $241.0 Million in Q4 and $975.8 Million in Full-Year Fiscal 2019
Organic Revenue Grew 3.2% in Q4 and 0.1% in Fiscal 2019Reduced Debt by $200 Million and Repurchased $50 Million of Shares in Fiscal 2019Board of Directors Authorizes New $50 Million Share Repurchase Program

TARRYTOWN, N.Y., May 09, 2019 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE: PBH) today reported financial results for its fourth quarter and twelve months ended March 31, 2019.

We again executed against our three-pillar strategy in... More